Send CathInfo's owner Matthew a gift from his Amazon wish list:
https://www.amazon.com/hz/wishlist/ls/25M2B8RERL1UO

Author Topic: Flu "Vaccine"  (Read 784 times)

0 Members and 1 Guest are viewing this topic.

Offline WhiteWorkinClassScapegoat

  • Full Member
  • ***
  • Posts: 1026
  • Reputation: +809/-773
  • Gender: Male
Flu "Vaccine"
« on: April 10, 2025, 08:31:27 PM »
  • Thanks!0
  • No Thanks!0


  • Bottom line of this video, Flu jab, calculated vaccine effectiveness of −26.9%

    N = 43,857

    ‘This study found a significantly higher risk of influenza among the vaccinated,

    compared to the unvaccinated state in northern Ohio during the 2024-2025 influenza season.’

    Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine (April 2023, Cleveland Clinic)

    https://academic.oup.com/ofid/article...

    ‘The higher the number of vaccines previously received, the higher the risk of contracting COVID-19’

    Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season

    https://www.medrxiv.org/content/10.11...

    Study to evaluate effectiveness of influenza vaccine during the 2024-2025 respiratory viral season.

    Methods

    Employees of Cleveland Clinic in employment in Ohio on October 1, 2024, were included.

    The cuмulative incidence of influenza,

    Vaccinated status

    Unvaccinated status

    Compared over the following 25 weeks.

    Results

    Among 53,402 employees, 43,857 (82.1%) had received the influenza vaccine by the end of the study.

    Influenza occurred in 1,079 (2.02%) during the study.

    The cuмulative incidence of influenza was similar for the vaccinated and unvaccinated states early,

    but over the course of the study the cuмulative incidence of influenza increased more rapidly among the vaccinated than the unvaccinated.

    In an analysis adjusted for age, sex, clinical nursing job, and employment location, the risk of influenza was significantly higher for the vaccinated compared to the unvaccinated state, HR, 1.27

    95% C.I., 1.07 – 1.51

    P = 0.007

    Yielding a calculated vaccine effectiveness of −26.9%

    95% C.I., −55.0 to −6.6%

    The results are generalizable to relatively healthy adults in the USA,

    which is a major target of adult influenza vaccination efforts.

    Although the study was done in northern Ohio,

    there is little reason to assume that the effectiveness of the vaccine would have been different in a different geographic region within the continental USA.


    Conclusions

    This study found that influenza vaccination of working-aged adults was associated with a higher risk of influenza during the 2024-2025 respiratory viral season,

    suggesting that the vaccine has not been effective in preventing influenza this season.

    Some details

    Influenza, respiratory viral infection, 145 000 deaths worldwide among all ages in 2017

    1918, case fatality rate 2.5%, more than 50 million deaths worldwide

    Seasonal pattern to illness

    Annual influenza vaccination is often recommended

    Trivalent inactivated vaccine (TIV), two influenza A virus types (H3N2 and H1N1),

    and an influenza B virus type

    Efficacy will vary depending on prognostication

    mRNA pressure?